Brad Loncar
Brad Loncar is the founder of BiotechTV, an independent media outlet that provides industry and company news, educational videos, and behind-the-scenes tours of the biotechnology industry. Since launching in June 2023, BiotechTV has grown in its scale and reach, now having three regional correspondents in San Diego, Philadelphia, and the United Kingdom and expanding the outlet’s regular shows to include BioVenture VoiCes, Biotech CEO Sisterhood, The Studio at Kendall Square, and Off-Target Effects.
Prior to launching BiotechTV, Brad was an independent biotech investor and analyst, managing a biotech-focused family office.
Through Loncar Investments LLC, he used his research of biotech companies and technologies to develop thematic biotech investment indexes, and he was the creator of two Nasdaq listed exchange traded funds.
Brad previously worked at Franklin Templeton Investments and served in a Senior Advisor role at the U.S. Department of the Treasury. Brad is one of the most followed biotech commentators on social media and regularly offers his own commentary on trending topics on X, formerly Twitter. He holds a BA in Finance from the University of Miami.
Follow BiotechTV
Also look for unique social pages for BiotechTV U.
.png){kind=logo}
Sponsor Spotlight
Evaluate is a trusted provider of forecasting and commercial intelligence to the pharmaceutical industry. With a combination of gold standard data sources and deep pharma expertise, Evaluate helps clients make the right portfolio decisions to drive growth.
​
​Evaluate's solutions provide a complete, dynamic view of development risk and commercial return across the full clinical lifecycle, underpinned by consensus forecasts to 2032, pipelines, deals and more. A consulting and analytics team is on always hand to help clients address unique clinical and commercial challenges.